• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Nanoform, Aprecia Partner to Advance 3DP Nanomedicines

    KemPharm Receives $10M Milestone for FDA Approval of Azstarys

    Valneva Focuses on Bilateral Discussions to Supply COVID-19 Vax

    Syneos, Medable Partner for New Decentralized Capabilities

    CSafe Global Appoints SVP of Technology and Innovation
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Evotec to Build Second Biologics Mfg. Facility in Toulouse

    Abenza Chooses North Carolina for New Biologics Manufacturing Site

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Recro, Ensysce Expand Development and Manufacturing Partnership

    Metrics Names Stephanie Emory Associate Director of Pharma Development
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    TraceLink Introduces Opus Platform

    Obituary Notice: Russell “Russ” Haines

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Nanoform, Aprecia Partner to Advance 3DP Nanomedicines

    KemPharm Receives $10M Milestone for FDA Approval of Azstarys

    Valneva Focuses on Bilateral Discussions to Supply COVID-19 Vax

    Syneos, Medable Partner for New Decentralized Capabilities

    Valneva’s Inactivated, Adjuvanted COVID-19 Vax Achieves Positive Data
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Unifying Quality Manufacturing to Drive Speed, Collaboration, and Compliance

    Ensuring Pharma Manufacturing Quality

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Baxter BioPharma Solutions

    Almac Group

    Quotient Sciences

    Syngene
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Adare Pharma Solutions

    Syngene

    Reed-Lane

    Baxter BioPharma Solutions

    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Expert's Opinion

    The Importance of Using an Accurate Pharmaceutical Composition Analyzer

    With one quick, nondestructive test, an accurate composition analyzer can provide the simultaneous analysis of the entire composition of the sample

    The Importance of Using an Accurate Pharmaceutical Composition Analyzer
    Related CONTENT
    • Mogene
    • Vetio Animal Health
    • Alcami Launches Rapid Sterility Offering
    • Anti-Counterfeiting in the Pharmaceutical Industry: An Evolution
    • NextPharma Completes Acquisition of Santen’s Tampere Manufacturing Facility
    Jeff Elliott, Contributing Writer10.15.19
    Few industries require as much care for precision and security as the pharmaceutical industry.  Every part of production and each end result must be made with the utmost accuracy and attention to detail.  As measurement requirements become more precise, exceptional accuracy becomes critical because too much or too little of a substance can significantly affect the potency, effectiveness, and overall safety of a drug.
     
    Under the FDA, United States Pharmacopeia (USP), and Pharmaceutical Microbiology Manual (PMM), pharmaceuticals are required to meet strict health and safety regulations when it comes to toxicity, sterility, and shelf life. 
     
    While pharmaceutical science is an increasingly exact industry, and the shelf-life of many products is closely monitored, impurities in a drug can have disastrous effects.  As pharmaceuticals are developed, transported, and stored for an indeterminate amount of time, at any stage from manufacturer to the consumer these substances and products may develop impurities that make them unsafe for use.
     
    Consequently, pharmaceuticals must be tested for impurities and changes in potency at each step to ensure that they continue to be safe for consumers.  Such testing can provide pharmaceutical companies the security of knowing that their products are continuously monitored for precision, correct composition, safety and compliance.
     
    However, conducting frequent compositional analysis tests throughout the process or in the field has traditionally been difficult.  In many cases, the primary barrier has been the expertise and time required to conduct such tests.  Multiple sophisticated measurement devices such as for moisture measurement and other elements of composition analysis had to be operated by trained personnel who could properly calibrate the equipment.  Many such tests also required meticulous sample preparation and disposal.
     
    Fortunately, a full range of composition analyzers from handheld to desktop and in-line are now available that can help to ensure that each product – every tablet or capsule – is safe to use and will work as intended. 
     
    “While composition analyzers are not new to the industry and their introduction helped to build momentum for the Process Analytical Technology (PAT) movement a decade ago, advanced units today allow even less-skilled personnel to take instant lab-quality tests,” says John Bogart, Managing Director of Kett US, a manufacturer of a full range of organic composition analyzers.  
     
    With a single fast, nondestructive test, a composition analyzer can now furnish analysis of a sample’s whole composition at once.  Such “point-and-measure” options enable multiple readings to be quickly taken at any stage of the process, as well as at loading docks, on trucks, at suppliers, or in bins, vats or vessels.
     
    Whether dealing in bulk, dose, tablets, capsules, gel, or liquid-based products, by simplifying the process, pharmaceutical manufacturers can increase the quality of their products from chemical receipt, formulation, and processing to end product manufacturing and distribution.
     
    The Many Benefits of Compositional Analysis
    In pharmaceutical manufacturing, determining a wide variety of compositional characteristics – such as the level of moisture, purity, or contaminants in raw inputs, in-process substances, and end products – can be essential to ensuring safety and compliance.
     
    Typically, pharmaceuticals require three primary tests including one that involves moisture.  One test determines solid content for quality and for dosage quantification.  Another test measures residual solvents, which are sometimes used in the chemistry of production; these need to be below a certain level to be “acceptable” for human consumption.  A third test relates to blend homogeneity.  When blending solids in a stream, it is necessary to ensure that the blend is sufficiently homogenous, so it is ready to move to the next processing step. 
     
    Composition meters can efficiently perform all three of these measurements in a single test.  Full-spectrum units can perform not only these three analyses, but also a vital test measuring Active Pharmaceutical Ingredients (APIs).
     
    As such, frequent compositional analysis can help pharmaceutical products stay compliant when sold based on regulated moisture content.  Moisture content is measured to get the solids content; and measuring the amount of solid in the dose is required to ensure that the patient receives the correct amount of API.  It is also necessary to measure the level of purity/contaminants and other factors that can affect safety and product effectiveness.  Prescribed percentages must be met in order to satisfy certain specifications, or the product/substance will not be accepted by the regulating agency. 
     
    Simplifying Compositional Analysis
    Although traditional laboratory and online based moisture measurement techniques are useful in the right settings, they have lacked the simplicity and flexibility required for frequent spot checks.
     
    One common test is a Karl Fischer (KF) test.  This procedure calls for chemical reagents to be added to the sample to separate the water from the remaining product.  The water removed is then compared with the initial mass or volume.  Samples are generally small, making the assumption that a large batch is homogenous.  Also, since the chemical reagents need to be used, skilled personnel are required to determine the initial parameters, confirm that the system is properly calibrated and maintained and, at times, required to actually conduct the tests.  Disposal of the reagents and waste can be subject to substantial documentation and costly handling.
     
    Another test used is Loss on Drying, which measures the total material weight change after drying.  However, such tests typically require a sample to be prepared and brought back to the lab.  The test takes at least 15 minutes to several hours to perform, which is too slow when more immediate measurements are required.  It also requires the sample to be altered or destroyed.
     
    Beyond this, there could be a number of additional primary tests required to determine other necessary characteristics, such as the level of purity or contaminants in a pharmaceutical substance or product.  Each of these tests usually requires separate tools, procedures, and sample preparation.  This requires not only skilled personnel but also extra time and labor for each separate measurement as well as the additional use of potentially very expensive product which is destroyed in these other tests.
     
    As a result, secondary test methods have typically been used to deliver faster results.  This type of test uses an indirect method and a single conversion to achieve accurate results.  Secondary measurement techniques are routinely accepted as equal to the gold standard method.   Examples are speedometers, common infrared and liquid thermometers and most pressure gauges.  If there is a disadvantage, it is that the instrument must first be calibrated to ensure accurate results.  In some cases, calibration could only be performed by trained staff familiar with the equipment.
     
    In response, industry innovators have developed a simplified approach that allows even less-trained personnel to take portable, desktop, or in-line, instant composition analysis readings of pharmaceutical industry feedstock, in-process formulations, or end products as needed.
     
    The approach involves devices that utilize Near-Infrared (NIR) light, a highly accurate, non-contact, secondary measurement method that can deliver immediate, laboratory quality composition analysis readings.
     
    “NIR composition analyzers allow very accurate, instant, simultaneous measurement of multiple organic components in solids and liquids without contact or sample preparation, so there is no product contamination when using handheld and inline/online models,” says Bogart. 
     
    In addition, because the process is non-destructive, samples remain unaltered so they can be used for additional tests or put back into the product stream.  Because no direct contact or sample alteration is required, particle size variation and unusual textures are not an issue.  This can be important when used with a range of chemicals, formulations, or end products in different settings.
     
    According to Bogart, once a composition analyzer has been calibrated against lab or production standards for the components to be measured (moisture, purity, etc.) the calibrations can be good for the life of the instrument.  The is true as the instrument can be continuously verified against stored optical standards that provide full traceability to the original measurement method, and the calibrations are stored in different “channels” in the instrument.
     
    “With a composition analyzer, a NIR light source is reflected off, or transmitted through the liquid or solid sample,” says Bogart.  “Several organic components can be measured in single test when the light resonates with certain molecules and the analyzer measures the sample’s light absorbance values, its ‘optical fingerprint.’  This is combined with the calibrations stored in different analyzer ‘channels’ to instantly display multiple simultaneous.”
     
    This means that when the sample’s compositional accuracy is being tested anywhere within the production process, from manufacturing to distributing, a composition analyzer is able to provide fast information for verification or validation of “release specs”. 
     
    Because accurate measurement is achieved without pre-processing the samples or waiting for lab results, this dramaticaly reduces the test cycle, enabling pharmaceutical manufacturers to focus on improving product quality and not on sampling and prep work.
     
    “The goal is for any staff member to be able to successfully use a composition analyzer whenever and wherever it is needed, with minimal required training,” says Bogart.  “This allows the pharmaceutical industry to be certain that products are of the highest quality.”
     
    “The key is to cost-effectively be able to conduct as much testing as required, with full confidence in the results, each and every time,” adds Bogart.


    Jeff Elliott is a Torrance, CA-based technical writer. He has researched and written about industrial technologies and issues for the past 20 years.
    Related Searches
    • Dosage
    • quality
    • fda
    • formulation
    Suggested For You
    Mogene Mogene
    Vetio Animal Health Vetio Animal Health
    Alcami Launches Rapid Sterility Offering Alcami Launches Rapid Sterility Offering
    Anti-Counterfeiting in the Pharmaceutical Industry: An Evolution Anti-Counterfeiting in the Pharmaceutical Industry: An Evolution
    NextPharma Completes Acquisition of Santen’s Tampere Manufacturing Facility NextPharma Completes Acquisition of Santen’s Tampere Manufacturing Facility
    Colorcon Launches $50M Venture Capital Fund Colorcon Launches $50M Venture Capital Fund
    Quality Metrics Feedback Quality Metrics Feedback
    FDA Extends CRADA with CluePoints FDA Extends CRADA with CluePoints
    Roche Wins Two Approvals for Cancer Drug Rozlytrek Roche Wins Two Approvals for Cancer Drug Rozlytrek
    Boston Analytical Continues Expansion Boston Analytical Continues Expansion
    Schreiner MediPharm, Applied DNA Offer Forensic Authentication Feature Schreiner MediPharm, Applied DNA Offer Forensic Authentication Feature
    Avomeen Appoints Project Director of Biological Chemistry Avomeen Appoints Project Director of Biological Chemistry
    NIIMBL, FDA to Advance Innovation in Bio Manufacturing NIIMBL, FDA to Advance Innovation in Bio Manufacturing
    FDA Accepts RedHill Biopharma’s NDA for Talicia FDA Accepts RedHill Biopharma’s NDA for Talicia
    Syndax Pharma Gets IND Clearance for Leukemia Treatment Syndax Pharma Gets IND Clearance for Leukemia Treatment

    Related Expert's Opinion

    • cGMP Manufacture | Drug Development | Scale-up/Technology Transfer
      Fast Track Automation in Pharmaceutical Manufacturing

      Fast Track Automation in Pharmaceutical Manufacturing

      Drug manufacturers turn to advanced automation technologies and project execution methodologies to reduce time, cost and risk
      Steve Zarichniak, Technical Solutions Consultant, Honeywell Process Solutions 03.25.21

    • Clinical Trials | Drug Development
      Regulatory Practices in a Post-Pandemic World

      Regulatory Practices in a Post-Pandemic World

      Envisioning the new normal for clinical development.
      Dr. Ronan Brown, SVP and Head of Integrated Global Compliance, IQVIA 03.22.21

    • Clinical Trials | Drug Development | Information Technology
      Virtual Clinical Trials: The Future of Dermatology Studies

      Virtual Clinical Trials: The Future of Dermatology Studies

      COVID-19 has created lasting impacts for clinical trials and a host of benefits have arisen from the adoption of virtual and hybrid models.
      Sonja VanWye, RN, MSN, Director, Dermatology Strategy, IQVIA Biotech 01.15.21


    • Clinical Trials | Drug Development
      The Slow – But Desperately Needed – Evolution of Oncology Clinical Development Designs

      The Slow – But Desperately Needed – Evolution of Oncology Clinical Development Designs

      Appropriate adaptive designs in early stages of development can accelerate timelines and reduce costs, and help focus on the most promising agents.
      Jürgen Hummel, MSc, Senior Director, Statistical Science, PPD, and Lead of PPD’s Adaptive Design Working Group 01.07.21

    • Drug Development | Industry News | Regulatory Affairs
      The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

      The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

      A look at EUA standards and approvals, unavoidable pitfalls, Operation Warp Speed, FDA’s use of Real-World Evidence, and a slow return to "normalcy".
      Chad Landmon, Michelle Divelbiss and Alex Alfano, Axinn, Veltrop & Harkrider LLP's Intellectual Property and Food and Drug Administration Practice Groups 01.05.21

    • Clinical Trials | Drug Development | Information Technology
      Advances in Intelligent Automation

      Advances in Intelligent Automation

      The future of medicine relies on further digital transformation and automation-enabling solutions to improve drug development and monitoring.
      Updesh Dosanjh, Practice Leader, Technology Solutions, IQVIA 12.14.20


    • Drug Development
      Navigating Uncertainty: Considerations for Life Sciences 2021

      Navigating Uncertainty: Considerations for Life Sciences 2021

      With vaccines against COVID-19 on the horizon, our focus is shifting to 2021 and the major issues life sciences companies face and reasons for optimism.
      Arda Ural , EY Americas Health Sciences and Wellness Industry Leader, Ernst & Young LLP 12.11.20

    • Drug Development
      New York City is Not Dead, Our Life Sciences Sector is Thriving

      New York City is Not Dead, Our Life Sciences Sector is Thriving

      Amid the COVID-19 pandemic, life sciences is booming in NYC!
      Sara Jane Demy, CEO & Founder, Demy-Colton 10.01.20

    • Clinical Trials | Drug Development
      How to Balance Internal and External Staff Within Outsourcing Models

      How to Balance Internal and External Staff Within Outsourcing Models

      Strategies to consider in flexed staffing models.
      John Barry, SVP, Consulting Practice and Chief Strategy Officer, PRA Health Sciences, SSD 09.22.20


    • Biologics, Proteins, Vaccines | Drug Development
      The Importance of Global Collaboration in the Fight Against COVID-19

      The Importance of Global Collaboration in the Fight Against COVID-19

      Industry continues to join forces to find new treatments for COVID-19.
      Dohyun Cho, Chief Operating Officer, Enzychem Lifesciences 09.08.20

    • Clinical Trials | Drug Development
      FDA Response to COVID-19

      FDA Response to COVID-19

      A Discussion on Protocol Amendments and Clinical Study Reports in Affected Ongoing Trials.
      Jack Modell, M.D., Vice President and Senior Medical Officer, Rho 09.03.20

    • Clinical Trials | Drug Development
      Beyond 2020: The Future of CROs

      Beyond 2020: The Future of CROs

      How will remote site access impact the CRO business?
      Ryan Jones, CEO, Florence Healthcare 08.21.20


    • Biologics, Proteins, Vaccines | Clinical Trials | Drug Development
      Global Biotech: Leading Health Care Innovation and How CROs Are Adapting to Meet Their Needs

      Global Biotech: Leading Health Care Innovation and How CROs Are Adapting to Meet Their Needs

      New models from CROs are enabling further biotech expansion
      Davide Garrisi, Biotech Portfolio Lead, PPD Biotech 08.20.20

    • Clinical Trials | Drug Development
      Pharma’s Imperative: Rethinking the FSP Outsourcing Paradigm

      Pharma’s Imperative: Rethinking the FSP Outsourcing Paradigm

      Evaluating outsourcing strategies amid a complex trial landscape to further enhance clinical operations.
      Michael D. Jones , Vice President of Clinical FSP Client Engagement, IQVIA 08.17.20

    • Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development
      Tackling Analytical Challenges in Gene Therapy

      Tackling Analytical Challenges in Gene Therapy

      Key considerations on how to navigate the field as a gene therapy developer.
      Khanh Ngo Courtney, Ph.D., Biologics Project Director, Avomeen 07.17.20

    Trending
    • Franco Negron Named CEO Of ApiJect Systems America
    • Carton Service Launches Custom Green Packaging Solutions
    • Valneva Focuses On Bilateral Discussions To Supply COVID-19 Vax
    • Thermo Fisher Acquires PPD For $17.4B
    • PRA Health Sciences Expands Pharmacovigilance Services
    Breaking News
    • Nanoform, Aprecia Partner to Advance 3DP Nanomedicines
    • KemPharm Receives $10M Milestone for FDA Approval of Azstarys
    • Valneva Focuses on Bilateral Discussions to Supply COVID-19 Vax
    • Syneos, Medable Partner for New Decentralized Capabilities
    • CSafe Global Appoints SVP of Technology and Innovation
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Ashland Supports the Nature Conservancy Forest Restoration Effort to Help Plant a Billion Trees
    Martin Bauer Announces Installation of Agile Filling System at Bethlehem, PA Facility
    PepsiCo and Ingredion Begin Pilot Partnership with Soil and Water Outcomes Fund
    Coatings World

    Latest Breaking News From Coatings World

    AkzoNobel Shareholders Approve Final Dividend at Annual General Meeting
    PPG Maintains EcoVadis Gold Rating
    Sustainable Plastics Will Make Up More Than 15% of Production by 2030
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Getinge Receives FDA Clearance for Multiple Products
    Study Shows Benefits of CCHD Screening Using Masimo SET Pulse Oximetry
    TEAM Technologies Acquires ViruDefense
    Contract Pharma

    Latest Breaking News From Contract Pharma

    RDIF, Minapharm to Make Over 40M Doses of the Sputnik V Vaccine in Egypt
    Bora Pharmaceuticals Completes Health Canada Inspection
    Nanoform, Aprecia Partner to Advance 3DP Nanomedicines
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Johnson & Johnson Reports Sales Increase in First Quarter of 2021
    THG Launches Recycling Program in UK
    Knoll Printing & Packaging Commits to a Healthy Ocean and Planet
    Happi

    Latest Breaking News From Happi

    L’Oréal Successfully Defends Itself In Patent Infringement Lawsuit
    TFF Names 2021 Honorees for Lifetime Achievement Perfumer and Hall of Fame
    Ashland Donates $20,000 To Help Plant Trees
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    SE-DA Invests in Kornit Presto S
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Ashland commits to forest restoration
    Epson upgrades SurePress demo facility
    Xeikon helps converters navigate toner and inkjet
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Savaré Strengthens Technical Support for the Americas
    FiberVisions, Avgol Partner with Polymateria
    High-Tech Conversions Launches Wipes Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA Clears Orthofix's 3D-Printed FORZA Titanium TLIF Spacer System
    Patients Conclude Clinical Visits in Knee Osteoarthritis Treatment Study
    SeaSpine Begins Limited Rollout of WaveForm TO 3D-Printed Interbodies
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Identiv, Ameta International Announce US, Canadian Distribution Partnership
    Adesis Achieves ISO 9001:2015 Certification
    Louis Widmer SA Complies with EU Anti-Counterfeiting Directive with Zebra Technologies’ Solution

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login